NF-Y activates genes of metabolic pathways altered in cancer cells

Paolo Benatti1, Maria Luisa Chiaramonte2, Mariangela Lorenzo2

  • 1Dipartimento di Scienze della Vita, Università di Modena e Reggio Emilia, Modena, Italy.

Oncotarget
|December 10, 2015
PubMed

Insights

The transcription factor NF-Y (Nuclear Factor Y) regulates metabolic genes crucial for cancer cell growth. It promotes anabolic pathways and glycolysis while repressing mitochondrial respiration, fueling tumor progression.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Metabolic Regulation

Background:

  • The transcription factor NF-Y binds to the CCAAT box, a DNA sequence found in promoters of genes overexpressed in tumors.
  • Previous studies indicated that NF-Y regulates genes involved in metabolism.

Purpose of the Study:

  • To dissect the specific metabolic genes targeted by NF-Y.
  • To integrate genomic binding data with gene expression profiles after NF-Y subunit inactivation.

Main Methods:

  • Genomic binding analysis of NF-Y.
  • Gene expression profiling after inactivation of NF-Y subunits in various cell types.

Main Results:

  • NF-Y controls de novo lipid biosynthesis in conjunction with SREBPs.
  • NF-Y activates glycolytic genes but represses mitochondrial respiratory genes.
  • NF-Y targets key metabolic pathways including SOCG, glutamine, polyamine, and purine biosynthesis.

Conclusions:

  • NF-Y orchestrates a metabolic strategy favoring anaerobic energy production and anabolic pathways common in cancer.
  • NF-Y directly controls critical cancer-driving metabolic nodes.
  • These findings reveal NF-Y's role in reprogramming cellular metabolism for tumor growth.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K